EZH2 and cancer: In summary, our findings uncover a previously unidentified role of ZMYND8 in regulating PRC2 activities and promoting a Polycomb-dependent to -independent switch of EZH2 functions in hypoxia-exposed or VHL-deficient cancer cells.